(Total Views: 129)
Posted On: 09/14/2021 9:43:01 AM
Post# of 43997

$GANX announced that Manolo Bellotto, Ph.D., General Manager and President at Gain, will present an overview on the Company’s proprietary Structurally Targeted Allosteric Regulators (STARs) for GM1 Gangliosidosis and Morquio B Disease.
https://finance.yahoo.com/news/gain-therapeut...00645.html
https://finance.yahoo.com/news/gain-therapeut...00645.html

